Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

Tessa G Steenbruggen, Sabine C Linn, Sjoerd Rodenhuis, Gabe S Sonke

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Metastatic breast cancer is generally considered incurable. However, some patients show an exceptional response to treatment and enjoy long-term survival in good health. Here, we present a remarkable example of a patient who is still in remission 19 years after high-dose chemotherapy and locoregional treatment for limited oligometastatic breast cancer. We will outline our rationale for this treatment to explain her excellent response and suggest strategies to select larger patient groups that could similarly benefit from existing treatment approaches.

Original languageEnglish
Article numbere433
Number of pages4
JournalCurēus
Volume7
Issue number12
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?'. Together they form a unique fingerprint.

Cite this